On Demand Webinars
Converging Innovations to Break Barriers in Neural Drug Discovery
RealBrain® microtissues, a family of class-leading 3D organotypic neural models, offer human-relevant alternatives to traditional animal models for high-throughput screening of potential drug candidates.
Innovative AI-Driven Solutions to Address the Growing Complexity of APIs
The complexity of small molecule active pharmaceutical ingredients (APIs) is rising, bringing longer syntheses that challenge innovators' timely readiness for the Clinic.
The road to commercial readiness: Mastering API production at every scale
Mastering the complexities of active pharmaceutical ingredient (API) commercial production is crucial for ensuring the consistent quality, efficacy, and safety of pharmaceutical products.
